New Drugs Controller General of India likely to be announced soon

The Union Public Service Commission (UPSC) conducted interviews for the appointment of the Drugs Controller General of India (DCGI) during this week. The top contenders are Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.

Earlier on November 16 last year, the tenure of Dr VG Somani as the DCGI was extended by three months for the second time. Somani had also got an extension in month of August 2022. Dr Kiran Kumar Karlapu, Deputy Secretary, Department of Health and Family Welfare issued the circular regarding the extension of DCGI for a further period of three months.

The DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country. It also has the authority to approve new drugs and regulate clinical trials.

  • Related Posts

    Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

    New Delhi: Even as global economic uncertainty drags down trade, Indian pharmaceutical exporters are seeing growth in Brazil and Nigeria as both countries are emerging as important overseas markets. Data…

    UP has emerged as India’s largest Healthcare & med tech hub: Yogi

    Lucknow: Chief Minister Yogi Adityanath on Sunday said that Uttar Pradesh is not merely a state with a population of 25 crore but has also emerged as the country’s largest hub…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

    Brazil, Nigeria emerge as key export destinations; market expands to $20.48 billion

    UP has emerged as India’s largest Healthcare & med tech hub: Yogi

    UP has emerged as India’s largest Healthcare & med tech hub: Yogi

    Centre flags serious lapses in state’s blood banks

    Centre flags serious lapses in state’s blood banks

    Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

    Sun Pharma Launches UNLOXCYT for Advanced Skin Cancer in US

    Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

    Unlicensed medical device stock worth Rs. 4.47 lakh seized in Gurugram raid

    Controlled substances charge: Court summons Ramdev, Amazon founder

    Controlled substances charge: Court summons Ramdev, Amazon founder